Randomized trial of denosumab in patients receiving adjuvant aromatase inhibitors for nonmetastatic breast cancer

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
Georgiana K EllisSusie Jun

Abstract

Adjuvant aromatase inhibitor therapy is well established in postmenopausal women with hormone receptor-positive breast cancer, but such therapy is complicated by accelerated bone loss and increased fracture risk. We investigated the ability of denosumab, a fully human monoclonal antibody against receptor activator of nuclear factor-kappaB ligand, to protect against aromatase inhibitor-induced bone loss. Eligible women with hormone receptor-positive nonmetastatic breast cancer treated with adjuvant aromatase inhibitor therapy were stratified by duration of aromatase inhibitor therapy (< or = 6 v > 6 months), received supplemental calcium and vitamin D, and were randomly assigned to receive placebo (n = 125) or subcutaneous denosumab 60 mg (n = 127) every 6 months. At enrollment, all patients were required to have evidence of low bone mass, excluding osteoporosis. The primary end point was percentage change from baseline at month 12 in lumbar spine bone mineral density (BMD). At 12 and 24 months, lumbar spine BMD increased by 5.5% and 7.6%, respectively, in the denosumab group versus placebo (P < .0001 at both time points). Increases were observed as early as 1 month and were not influenced by duration of aromatase inhibitor ther...Continue Reading

References

Feb 20, 1998·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·P DombernowskyP F Trunet
May 9, 1998·Proceedings of the National Academy of Sciences of the United States of America·H YasudaT Suda
May 4, 1999·The Journal of Cell Biology·T L BurgessD L Lacey
Sep 10, 2003·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Bruce E HillnerUNKNOWN American Society of Clinical Oncology
Jan 13, 2004·Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists·Stephen F HodgsonUNKNOWN AACE Osteoporosis Task Force
Mar 12, 2004·The New England Journal of Medicine·R Charles CoombesUNKNOWN Intergroup Exemestane Study
Nov 17, 2004·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Eric P WinerMark R Somerfield
Jun 23, 2005·The Journal of Steroid Biochemistry and Molecular Biology·Richard Eastell, Rosemary Hannon
Jun 29, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Per E LønningGiorgio Massimini
Jul 13, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Francesco BoccardoPiero Sismondi
Dec 31, 2005·The New England Journal of Medicine·UNKNOWN Breast International Group (BIG) 1-98 Collaborative GroupAron Goldhirsch
Feb 24, 2006·The New England Journal of Medicine·Michael R McClungUNKNOWN AMG 162 Bone Loss Study Group
Dec 13, 2006·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Adam BrufskyEdith A Perez
Dec 13, 2006·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Michael F X GnantUNKNOWN Austrian Breast and Colorectal Cancer Study Group
May 9, 2007·Breast Cancer : the Journal of the Japanese Breast Cancer Society·Toshiaki UtsumiHidetaka Hanada
Jun 15, 2007·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Manfred KaufmannGunter von Minckwitz
Aug 22, 2007·Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research·E Michael LewieckiUNKNOWN AMG 162 Bone Loss Study Group

❮ Previous
Next ❯

Citations

Mar 30, 2011·Journal of Molecular Medicine : Official Organ of the Gesellschaft Deutscher Naturforscher Und Ärzte·Reiko HanadaJosef M Penninger
Jun 24, 2010·Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·S Ferrari-Lacraz, S Ferrari
Sep 6, 2011·Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·N B WattsS Ferrari
Jan 19, 2011·Cancer Immunology, Immunotherapy : CII·Evangelos Terpos, Meletios A Dimopoulos
Aug 3, 2010·Rheumatology International·Pooneh Salari SharifBagher Larijani
Aug 18, 2010·Wiener medizinische Wochenschrift·Eduardo Maldonado-Gonzales, Peter Pietschmann
Feb 17, 2010·Breast Cancer Research and Treatment·Omar S DinRobert E Coleman
May 22, 2010·Breast Cancer Research and Treatment·Allan Lipton
Oct 12, 2011·Breast Cancer Research and Treatment·Dulcinea Candelaria-QuintanaMelanie E Royce
Nov 5, 2009·Journal of General Internal Medicine·Philip J SaylorMatthew R Smith
Sep 3, 2011·Current Treatment Options in Oncology·Keo Tabane, Daniel A Vorobiof
Apr 29, 2010·Current Oncology Reports·Saby GeorgeRonald M Bukowski
Nov 6, 2010·Current Oncology Reports·Allan Lipton
Dec 7, 2010·Current Osteoporosis Reports·Cesar E BogadoJose R Zanchetta
Dec 17, 2010·Current Osteoporosis Reports·Jean-Baptiste LattoufFred Saad
Dec 20, 2011·Endocrine·G MazziottiA Giustina
May 15, 2012·Endocrine·Kathrin SinningenLorenz C Hofbauer
Aug 26, 2011·Cancer Microenvironment : Official Journal of the International Cancer Microenvironment Society·Kimberly Noonan, Ivan Borrello
Apr 3, 2013·European Journal of Pharmacology·Jan C DroogerAgnes Jager
Jan 1, 2012·BoneKEy Reports·Deborah L GalsonG David Roodman
Jan 1, 2012·BoneKEy Reports·Armelle DufresneJean-Yves Blay
Jan 1, 2012·BoneKEy Reports·Jean-Jacques Body
Sep 3, 2010·Nature Reviews. Clinical Oncology·Tomifumi OnishiNaoto T Ueno
Apr 1, 2010·Nature Reviews. Clinical Oncology·Eitan AmirMark Clemons
Jan 11, 2012·Nature Reviews. Clinical Oncology·Janet E Brown, Robert E Coleman
May 1, 2012·Nature Reviews. Drug Discovery·David L LaceyRoger Dansey
Mar 20, 2013·Nature Reviews. Rheumatology·Robert E ColemanJanet E Brown
Nov 11, 2009·Prostate Cancer and Prostatic Diseases·P J Saylor, M R Smith
Aug 29, 2012·Pediatric Research·Renee BargmanNancy Pleshko
Aug 13, 2009·The New England Journal of Medicine·Matthew R SmithUNKNOWN Denosumab HALT Prostate Cancer Study Group
Mar 19, 2011·Annals of Oncology : Official Journal of the European Society for Medical Oncology·P HadjiA Lipton
Oct 18, 2011·Annals of Oncology : Official Journal of the European Society for Medical Oncology·K ZamanUNKNOWN Swiss Group for Clinical Cancer Research (SAKK)
Mar 25, 2011·Chemotherapy·S LeoV Lorusso
Nov 1, 2009·Therapeutic Advances in Medical Oncology·Michael GnantRaimund Jakesz
May 1, 2010·Therapeutic Advances in Medical Oncology·Joaquim Bellmunt, William K Oh
Oct 1, 2011·Therapeutic Advances in Medical Oncology·Guenther G Steger, Rupert Bartsch
Sep 10, 2009·Immunity & Ageing : I & a·Giuseppina CampisiDomenico Lio
Oct 14, 2010·CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne·Alexandra PapaioannouUNKNOWN Scientific Advisory Council of Osteoporosis Canada
Aug 20, 2011·European Journal of Endocrinology·Elena TsourdiLorenz C Hofbauer

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
James E LesterR E Coleman
The New England Journal of Medicine
Matthew R SmithDenosumab HALT Prostate Cancer Study Group
The Journal of Clinical Endocrinology and Metabolism
Henry G BoneJavier San Martin
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
Bruce E HillnerAmerican Society of Clinical Oncology
© 2022 Meta ULC. All rights reserved